|
|
| Research article summary (published 29 Jun 2009): |
Distortion maps from preferential hyperacuity perimetry are helpful in monitoring functional response to Lucentis therapy.
Full Abstract
PURPOSE: To use preferential hyperacuity perimetry to obtain a quantitative measure of central visual field distortion that would aid in the monitoring of functional responsiveness to ranibizumab treatment. METHODS: This study is a retrospective analysis of data from patients with neovascular age-related macular degeneration treated with ranibizumab. Preferential hyperacuity perimetry (PHP) were performed before and within 10 days of treatment. Pre- and posttreatment PHP metamorphopsia maps of contours showing 6 levels of metamorphopsia severity (S1 through S6; least to most distortion) were analyzed. Optical coherence tomography (OCT) outputs were subjected to standardized grading to generate metrics on subretinal fluid height, maximum retinal thickness, outer high-reflectivity band thickness, and height of pigment epithelial detachment (OCT metrics). RESULTS: Complete data were available from 17 patients. Statistically significant reductions were seen between baseline and posttreatment in PHP contour areas and OCT metrics, except for maximum retinal thickness. Mean best-corrected visual acuity improved by two letters, but this was not statistically significant. Change in PHP parameters correlated strongly with change in subretinal fluid height, with P values of <0.01 for most comparisons. Change in best-corrected visual acuity did not correlate with change in any of the OCT metrics or PHP distortion map areas. CONCLUSION: The reduction in the contour map area seen on PHP outputs occurs rapidly and correlates with the resolution of subretinal fluid, suggesting that this parameter may be used to monitor response to therapy.
Author information
Author/s: Das, Radha (R); Shi, Yanyun (Y); Silvestri, Guiliana (G); Chakravarthy, Usha (U);
Affiliation: Centre for Vision Sciences, Queen's University of Belfast, Institute of Clinical Science, Belfast, Northern Ireland.
Journal and publication information
Publication Type: Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
Journal: Retina (Philadelphia, Pa.) (Retina), published in United States. (Language: eng)
Reference: -2009 Jul-Aug; vol 29 (issue 7) : pp 1013-8
Dates: Created 2009/07/08; Completed 2009/10/06;
PMID: 19584658, status: MEDLINE (last retrieved date: 10/6/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Antibodies, Monoclonal (0) ; ranibizumab (0)Related articles
These are the most related articles currently in our database:
- Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization study.
29 Sep 2005 - Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration.
9 Apr 2008 - Treatment of naïve lesions in neovascular age-related macular degeneration with pegaptanib.
30 Aug 2007 - Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial.
30 Oct 2007 - Fixation pattern and macular sensitivity in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. A microperimetry study.
28 Feb 2004 - Intravitreal bevacizumab therapy for neovascular age-related macular degeneration: a pilot study.
26 Sep 2006 - Photodynamic therapy with verteporfin for peripapillary choroidal neovascularization.
30 Dec 2004 - Comparison of the original Amsler grid with the preferential hyperacuity perimeter for detecting choroidal neovascularization in age-related macular degeneration.
30 Aug 2007 - [Stability of postoperative visual acuity after rt-PA -SF6-treatment of submacular hemorrhage in age-related macular degeneration]
29 Apr 2004 - Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
30 Mar 2007
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.